Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

424 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cisplatin resistance and oncogenes--a review.
Dempke W, Voigt W, Grothey A, Hill BT, Schmoll HJ. Dempke W, et al. Among authors: schmoll hj. Anticancer Drugs. 2000 Apr;11(4):225-36. doi: 10.1097/00001813-200004000-00001. Anticancer Drugs. 2000. PMID: 10898536 Review.
Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial.
Arnold D, Voigt W, Kiewe P, Behrmann C, Lindemann S, Reif S, Wiesinger H, Giurescu M, Thiel E, Schmoll HJ. Arnold D, et al. Among authors: schmoll hj. Br J Cancer. 2009 Oct 20;101(8):1241-7. doi: 10.1038/sj.bjc.6605327. Epub 2009 Sep 22. Br J Cancer. 2009. PMID: 19773753 Free PMC article. Clinical Trial.
Impact of quality of life parameters and coping strategies on postchemotherapy nausea and vomiting.
Jordan K, Grothey A, Pelz T, Lautenschläger C, Franke U, Schöber C, Schmoll HJ. Jordan K, et al. Among authors: schmoll hj. Eur J Cancer Care (Engl). 2010 Sep;19(5):603-9. doi: 10.1111/j.1365-2354.2009.01099.x. Epub 2009 Aug 31. Eur J Cancer Care (Engl). 2010. PMID: 19725867
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C; German Testicular Cancer Study Group. Schmoll HJ, et al. J Clin Oncol. 2003 Nov 15;21(22):4083-91. doi: 10.1200/JCO.2003.09.035. Epub 2003 Oct 20. J Clin Oncol. 2003. PMID: 14568987 Clinical Trial.
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
Bokemeyer C, Kollmannsberger C, Stenning S, Hartmann JT, Horwich A, Clemm C, Gerl A, Meisner C, Rückerl CP, Schmoll HJ, Kanz L, Oliver T. Bokemeyer C, et al. Among authors: schmoll hj. Br J Cancer. 2004 Aug 16;91(4):683-7. doi: 10.1038/sj.bjc.6602020. Br J Cancer. 2004. PMID: 15266338 Free PMC article. Clinical Trial.
The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors.
Grothey A, Voigt W, Schöber C, Müller T, Dempke W, Schmoll HJ. Grothey A, et al. Among authors: schmoll hj. J Cancer Res Clin Oncol. 1999;125(3-4):166-73. doi: 10.1007/s004320050259. J Cancer Res Clin Oncol. 1999. PMID: 10235470 Review.
Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity.
Bokemeyer C, Fels LM, Dunn T, Voigt W, Gaedeke J, Schmoll HJ, Stolte H, Lentzen H. Bokemeyer C, et al. Among authors: schmoll hj. Br J Cancer. 1996 Dec;74(12):2036-41. doi: 10.1038/bjc.1996.673. Br J Cancer. 1996. PMID: 8980410 Free PMC article.
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.
Bokemeyer C, Beyer J, Metzner B, Ruther U, Harstrick A, Weissbach L, Kohrmann U, Verbeek W, Schmoll HJ. Bokemeyer C, et al. Among authors: schmoll hj. Ann Oncol. 1996 Jan;7(1):31-4. doi: 10.1093/oxfordjournals.annonc.a010473. Ann Oncol. 1996. PMID: 9081388
A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors.
Bokemeyer C, Köhrmann O, Tischler J, Weissbach L, Räth U, Haupt A, Schöffski P, Harstrick A, Schmoll HJ. Bokemeyer C, et al. Among authors: schmoll hj. Ann Oncol. 1996 Dec;7(10):1015-21. doi: 10.1093/oxfordjournals.annonc.a010493. Ann Oncol. 1996. PMID: 9037359 Clinical Trial.
Management of other non-cisplatin-induced emesis.
Schmoll HJ, Casper J. Schmoll HJ, et al. Oncology. 1996 Jun;53 Suppl 1:51-5. doi: 10.1159/000227641. Oncology. 1996. PMID: 8692552 Review.
424 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback